Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 7/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | STK17B | O94768 | 1/20 | 0.39 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14439576 | 0.97 | CA14 (0.60) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL13004665 | 0.94 | CA14 (0.59) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL18950461 | 0.94 | CA14 (0.63) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL8021860 | 0.92 | CA14 (0.68) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL8719347 | 0.92 | CA14 (0.68) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL13055410 | 0.92 | CA14 (0.68) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL8714161 | 0.92 | CA14 (0.68) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL31040441 | 0.92 | CA14 (0.55) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL15121181 | 0.91 | CA14 (0.54) | CA14TDP1MEN1KMT2AGAA | |
| SCHEMBL18116810 | 0.90 | CA14 (0.59) | CA14TDP1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181743-A1 | FUNCTIONAL LIPID DERIVATIVES AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181743-A1 | FUNCTIONAL LIPID DERIVATIVES AND USES THEREOF | LIPA, LIPG, LIPC | CA14 2506/4885TDP1 630/4885MEN1 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.